The Analysis of Aisling Capital Management LP's Holdings & P&L

Currently, Aisling Capital Management LP holds 13 types of securities in its portfolio with a total value $476.3M. In the most recent quarter, they have increased their positions in BBOT (+453.4K shares, valued at $4.1M), EPRX (+325.0K shares, valued at $2.4M), GLUE (+83.3K shares, valued at $1.4M); initiated new positions in EPRX (+325.0K shares, valued at $2.4M).

1M P&L

+152.7M+34.73%

3M P&L

+110.1M+22.82%

HY P&L

+86.8M+17.16%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology466.7M

98.0%

2Medical Care Facilities7.9M

1.7%

3Diagnostics & Research1.6M

0.3%

Top Industries by Stock Count

1Biotechnology11 stocks

84.6%

2Diagnostics & Research1 stocks

7.7%

3Medical Care Facilities1 stocks

7.7%

Sponsored

Stock Holdings

TickerCompany NameSharesShares △%Event DateReport DateHistory

BBIO BridgeBio Pharma Inc. (BBIO)5.1M shares0.00%2026-03-312026-05-05

SNDX Syndax Pharmaceuticals, Inc. (SNDX)1.3M shares0.00%2026-03-312026-05-05

GLUE Monte Rosa Therapeutics Inc (GLUE)1.6M shares5.66%2026-03-312026-05-05

BCAX Bicara Therapeutics Inc. (BCAX)568.9K shares0.00%2026-03-312026-05-05

BBOT BridgeBio Oncology Therapeutics (BBOT)1.0M shares80.30%2026-03-312026-05-05

CMPS Compass Pathways Plc (CMPS)1.4M shares19.52%2026-03-312026-05-05

SRRK Scholar Rock Holding Corporation (SRRK)77.0K shares0.00%2026-03-312026-05-05

BMEA Biomea Fusion Inc (BMEA)2.0M shares0.00%2026-03-312026-05-05

Sponsored

EPRX Eupraxia Pharmaceuticals Inc. (EPRX)325.0K sharesnew addition2026-03-312026-05-05

URGN Urogen Pharma Ltd. (URGN)108.0K shares0.00%2026-03-312026-05-05

ACRS Aclaris Therapeutics Inc (ACRS)434.5K shares0.00%2026-03-312026-05-05

MRKR Marker Therapeutics, Inc. (MRKR)325.4K shares0.00%2026-03-312026-05-05

OKUR OnKure Therapeutics, Inc. (OKUR)88.6K shares0.00%2026-03-312026-05-05

BBIO

BridgeBio Pharma Inc. (BBIO)

0.00%

Shares5.1M

Event2026-03-31

Filed2026-05-05

SNDX

Syndax Pharmaceuticals, Inc. (SNDX)

0.00%

Shares1.3M

Event2026-03-31

Filed2026-05-05

GLUE

Monte Rosa Therapeutics Inc (GLUE)

5.66%

Shares1.6M

Event2026-03-31

Filed2026-05-05

BCAX

Bicara Therapeutics Inc. (BCAX)

0.00%

Shares568.9K

Event2026-03-31

Filed2026-05-05

BBOT

BridgeBio Oncology Therapeutics (BBOT)

80.30%

Shares1.0M

Event2026-03-31

Filed2026-05-05

CMPS

Compass Pathways Plc (CMPS)

19.52%

Shares1.4M

Event2026-03-31

Filed2026-05-05

SRRK

Scholar Rock Holding Corporation (SRRK)

0.00%

Shares77.0K

Event2026-03-31

Filed2026-05-05

BMEA

Biomea Fusion Inc (BMEA)

0.00%

Shares2.0M

Event2026-03-31

Filed2026-05-05

EPRX

Eupraxia Pharmaceuticals Inc. (EPRX)

New

Shares325.0K

Event2026-03-31

Filed2026-05-05

URGN

Urogen Pharma Ltd. (URGN)

0.00%

Shares108.0K

Event2026-03-31

Filed2026-05-05

ACRS

Aclaris Therapeutics Inc (ACRS)

0.00%

Shares434.5K

Event2026-03-31

Filed2026-05-05

MRKR

Marker Therapeutics, Inc. (MRKR)

0.00%

Shares325.4K

Event2026-03-31

Filed2026-05-05

OKUR

OnKure Therapeutics, Inc. (OKUR)

0.00%

Shares88.6K

Event2026-03-31

Filed2026-05-05

Call Option Holdings

No call option holdings data available

Put Option Holdings

No put option holdings data available